Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 2668

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 7
Chunk 2668
---
     -  
        
     418,316 
  
    Issuance
    of Series A shares for rounding purchases 
     3  
     1,875  
     -  
     -  

     -  
     -  
     130  
     -  
        
     2,005 
  
    Issuance
    of common stock for Arena Equity Line of Credit (ELOC) commitment fee 
     -  
     -  
     -  
     -  

     3,456  
     -  
     500,000  
     -  
        
     500,000 
  
    Issuance
    of shares of Common Stock for Keystone ELOC commitment fee 
     -  
     -  
     -  
     -  
     -  
     -  
     18,644  
     2  
     (2) 
     -  
     -  
     - 
  
    Purchases
of shares of Common Stock under Keystone ELOC, net of issuance costs of $130,321 
     -  
     -  
     -  
     -  
     -  
     -  
     453,500  
     46  
     4,809,657  
     (716,694) 
     -  
     4,093,009 
  
    Issuance
    of shares of Common Stock upon conversion of Series A Preferred Stock 
     (10,073) 
     (8,760,824) 
     -  
     -  
     -  
     -  
     1,723,880  
     172  
     8,760,652  
     -  
     -  
     - 
  
    Issuance
    of shares of Common Stock upon conversion of Series B Preferred Stock 
     -  
     -  
     (353) 
     (281,949) 
     -  
     -  
     53,815  
     5  
     281,944  
     -  
     -